Mingli Gong

Beijing, 100084, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

EIF4H and YBX1 are essential host factors for hepatitis E virus replication and pathogenesis.

EIF4H and YBX1 are essential host factors for hepatitis E virus replication and pathogenesis.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 04, 2026

Bruton's tyrosine kinase inhibitor BTKi-2 inhibits mpox virus and vaccinia virus infection.

Bruton's tyrosine kinase inhibitor BTKi-2 inhibits mpox virus and vaccinia virus infection.

Journal: Virologica Sinica
Published: December 10, 2025

Zika virus NS5 protein inhibits type I interferon signaling via CRL3 E3 ubiquitin ligase-mediated degradation of STAT2.

Zika virus NS5 protein inhibits type I interferon signaling via CRL3 E3 ubiquitin ligase-mediated degradation of STAT2.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 15, 2024

Establishment of replication-competent vesicular stomatitis virus recapitulating SADS-CoV entry.

Establishment of replication-competent vesicular stomatitis virus recapitulating SADS-CoV entry.

Journal: Journal of virology
Published: April 01, 2024

Genome-wide CRISPR/Cas9 screen identifies SLC39A9 and PIK3C3 as crucial entry factors for Ebola virus infection.

Genome-wide CRISPR/Cas9 screen identifies SLC39A9 and PIK3C3 as crucial entry factors for Ebola virus infection.

Journal: PLoS pathogens
Published: February 17, 2024

Modeling antiviral response in the liver using human pluripotent stem cell-derived macrophages.

Modeling antiviral response in the liver using human pluripotent stem cell-derived macrophages.

Journal: Life medicine
Published: June 27, 2023

Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion.

Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion.

Journal: mBio
Published: March 10, 2022

Mutation Y453F in the spike protein of SARS-CoV-2 enhances interaction with the mink ACE2 receptor for host adaption.

Mutation Y453F in the spike protein of SARS-CoV-2 enhances interaction with the mink ACE2 receptor for host adaption.

Journal: PLoS pathogens
Published: July 27, 2021

Novel quinolone derivatives targeting human dihydroorotate dehydrogenase suppress Ebola virus infection in vitro.

Novel quinolone derivatives targeting human dihydroorotate dehydrogenase suppress Ebola virus infection in vitro.

Journal: Antiviral research
Published: June 23, 2021

Comparison of viral RNA-host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2.

Comparison of viral RNA-host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2.

Journal: Cell research
Published: June 02, 2021

Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2.

Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 04, 2021

A novel cell culture system modeling the SARS-CoV-2 life cycle.

A novel cell culture system modeling the SARS-CoV-2 life cycle.

Journal: PLoS pathogens
Published: January 20, 2021
Showing 1-12 of 15

Last Updated: 09/26/2026